BASF increases prices for pharmaceutical excipients and active ingredients

31-Aug-2011 - Germany

Effective September 1, 2011, BASF will increase the sales prices globally for all pharmaceutical excipients and generic active pharmaceutical ingredients by 10%.

This price increase affects the entire excipients portfolio including all binders, disintegrants, coatings, solubilizers, and solvents. The affected generic active pharmaceutical ingredient (API) portfolio contains products like Ibuprofen, Caffeine, and Pseudoephedrine.

Due to the continued rise in costs for raw materials, energy and labor this price increase has become necessary. All existing contractual obligations will be honored.

Other news from the department price development

These products might interest you

Pharmaceutical Substances

Pharmaceutical Substances by Thieme Verlag

Look up Industrial Syntheses of 2,600 APIs

Your tool for Syntheses, Patents and Applications – Pharmaceutical Substances

technical literature
KNAUER IJM NanoScaler

KNAUER IJM NanoScaler by KNAUER

Efficient formulation of lipid nanoparticles for RNA-based therapies

Optimise drug encapsulation from 1 ml to hundreds of millilitres with minimal drug input

formulation systems
Loading...

More news from our other portals

All FT-IR spectrometer manufacturers at a glance